NVAX Collar Strategy

NVAX (Novavax, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.

NVAX (Novavax, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.46B, a beta of 2.41 versus the broader market, a 52-week range of 6.2-11.97, average daily share volume of 4.8M, a public-listing history dating back to 1995, approximately 952 full-time employees. These structural characteristics shape how NVAX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.41 indicates NVAX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a collar on NVAX?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

Current NVAX snapshot

As of June 30, 2026, spot at $9.39, ATM IV 78.41%, IV rank 24.44%, expected move 22.48%. The collar on NVAX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 31-day expiry.

Why this collar structure on NVAX specifically: IV regime affects collar pricing on both sides; compressed NVAX IV at 78.41% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 22.48% (roughly $2.11 on the underlying). The 31-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated NVAX expiries trade a higher absolute premium for lower per-day decay. Position sizing on NVAX should anchor to the underlying notional of $9.39 per share and to the trader's directional view on NVAX stock.

NVAX collar setup

The NVAX collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With NVAX near $9.39, the first option leg uses a $10.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed NVAX chain at a 31-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 NVAX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$9.39long
Sell 1Call$10.00$0.60
Buy 1Put$9.00$0.61

NVAX collar risk and reward

Net Premium / Debit
-$940.00
Max Profit (per contract)
$60.00
Max Loss (per contract)
-$40.00
Breakeven(s)
$9.40
Risk / Reward Ratio
1.500

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

NVAX collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on NVAX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

NVAX collar profit and loss curve at expiration with breakevens and current spot markedNVAX collar payoff at expiration-$40-$20$0$20$40$60$5$10$15Underlying Price ($)P&L at Expiration ($)BE $9.40Spot $9.39
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-99.9%-$40.00
$2.09-77.8%-$40.00
$4.16-55.7%-$40.00
$6.24-33.6%-$40.00
$8.31-11.5%-$40.00
$10.39+10.6%+$60.00
$12.46+32.7%+$60.00
$14.54+54.8%+$60.00
$16.61+76.9%+$60.00
$18.69+99.0%+$60.00

When traders use collar on NVAX

Collars on NVAX hedge an existing long NVAX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

NVAX thesis for this collar

The market-implied 1-standard-deviation range for NVAX extends from approximately $7.28 on the downside to $11.50 on the upside. A NVAX collar hedges an existing long NVAX position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current NVAX IV rank near 24.44% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on NVAX at 78.41%. As a Healthcare name, NVAX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to NVAX-specific events.

NVAX collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. NVAX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move NVAX alongside the broader basket even when NVAX-specific fundamentals are unchanged. Always rebuild the position from current NVAX chain quotes before placing a trade.

Frequently asked questions

What is a collar on NVAX?
A collar on NVAX is the collar strategy applied to NVAX (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With NVAX stock trading near $9.39, the strikes shown on this page are snapped to the nearest listed NVAX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are NVAX collar max profit and max loss calculated?
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the NVAX collar priced from the end-of-day chain at a 30-day expiry (ATM IV 78.41%), the computed maximum profit is $60.00 per contract and the computed maximum loss is -$40.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a NVAX collar?
The breakeven for the NVAX collar priced on this page is roughly $9.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current NVAX market-implied 1-standard-deviation expected move is approximately 22.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on NVAX?
Collars on NVAX hedge an existing long NVAX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current NVAX implied volatility affect this collar?
NVAX ATM IV is at 78.41% with IV rank near 24.44%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related NVAX analysis